Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Open Biology
|
August 12, 2016
Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers
Ailsa Bennett, Olivia Sloss, Caroline Topham, et al.
NAR Cancer
|
November 16, 2022
Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors
Anya Golder, Louisa Nelson, Anthony Tighe, et al.
Genome Medicine
|
September 2, 2021
Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes
Bethany M Barnes, Louisa Nelson, Anthony Tighe, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology
|
August 17, 2023
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability
Louisa Nelson, Bethany M Barnes, Anthony Tighe, et al.
Cell Reports. Medicine
|
June 4, 2025
Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancer
Anthony Tighe, Louisa Nelson, Robert D Morgan, et al.
Iscience
|
June 9, 2025
Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYC
Samantha Littler, Bethany M Barnes, Rhys Owen, et al.
BMC Cancer
|
November 10, 2020
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancer
Mark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 17, 2021
Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models
Camilla Coulson-Gilmer, Robert D Morgan, Louisa Nelson, et al.
Cancer Cell
|
July 16, 2015
MYC Is a Major Determinant of Mitotic Cell Fate
Caroline Topham, Anthony Tighe, Peter Ly, et al.
Disease Models & Mechanisms
|
September 27, 2021
TP53 loss initiates chromosomal instability in fallopian tube epithelial cells
Daniel Bronder, Anthony Tighe, Darawalee Wangsa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Open Biology
|
August 12, 2016
Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers
Ailsa Bennett, Olivia Sloss, Caroline Topham, et al.
NAR Cancer
|
November 16, 2022
Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors
Anya Golder, Louisa Nelson, Anthony Tighe, et al.
Genome Medicine
|
September 2, 2021
Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes
Bethany M Barnes, Louisa Nelson, Anthony Tighe, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology
|
August 17, 2023
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability
Louisa Nelson, Bethany M Barnes, Anthony Tighe, et al.
Cell Reports. Medicine
|
June 4, 2025
Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancer
Anthony Tighe, Louisa Nelson, Robert D Morgan, et al.
Iscience
|
June 9, 2025
Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYC
Samantha Littler, Bethany M Barnes, Rhys Owen, et al.
BMC Cancer
|
November 10, 2020
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancer
Mark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 17, 2021
Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models
Camilla Coulson-Gilmer, Robert D Morgan, Louisa Nelson, et al.
Cancer Cell
|
July 16, 2015
MYC Is a Major Determinant of Mitotic Cell Fate
Caroline Topham, Anthony Tighe, Peter Ly, et al.
Disease Models & Mechanisms
|
September 27, 2021
TP53 loss initiates chromosomal instability in fallopian tube epithelial cells
Daniel Bronder, Anthony Tighe, Darawalee Wangsa, et al.
Page
of 2